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Abstract
A novel peptide was purified from the venom of the scorpion Androctonus australis Garzoni (abbreviated Aa1,
corresponding to the systematic number alpha KTX4.4). It contains 37 amino acid residues, has a molecular mass of 3850
Da, is closely packed by three disulfide bridges and a blocked N-terminal amino acid. This peptide selectively affects the K
currents recorded from cerebellum granular cells. Only the fast activating and inactivating current, with a kinetics similar to
IA-type current, is completely blocked by the addition of low micromolar concentrations (Ki value of 150 nM) of peptide Aa1
to the external side of the cell preparation. The blockade is partially reversible in our experimental conditions. Aa1 blocks the
channels in both the open and the closed states. The blockage is test potential independent and is not affected by changes in
the holding potential. The kinetics of the current are not affected by the addition of Aa1 to the preparation; it means that the
block is a simple ‘plugging mechanism’, in which a single toxin molecule finds a specific receptor site in the external vestibule
of the K channel and thereby occludes the outer entry to the K conducting pore. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Review of recent literature shows an increasing
interest in the search and use of venom components
as tools for neurobiological studies [1^5]. For exam-
ple, the knowledge of the structure and function of
potassium channels has been greatly increased by the
discovery of speci¢c natural peptide inhibitors used
as probes at the molecular level [6^8]. The neurotoxic
peptides, found in scorpion venoms, act speci¢cally
as high-a⁄nity K channel blockers [3,9^11]. They
have proven to be useful tools for channel puri¢ca-
tion [12^14], for structure^function analysis of volt-
age-gated and Ca2-activated K channels [15^18]
and for the pharmacological classi¢cation of the dif-
ferent K-channel currents [1,19,20]. From the ven-
om of North-African and Middle-East scorpions sev-
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eral such peptides have been isolated and character-
ized, from which Charybdotoxin has been the most
widely studied [8]. Androctonus mauritanicus scorpion
venom contains a toxin, P05, which is structurally
and functionally similar to the leiurotoxin I (from
the scorpion Leiurus quinquestriatus), a blocker of
the apamin-sensitive Ca2-activated K channels
[21]. Similarly, Kaliotoxin and Agitoxin are peptides
from scorpions of the species A. mauritanicus mau-
ritanicus 3 and L. quinquestriatus var. hebraeus [1,10],
respectively, used to characterize several types of K
channels.
In this communication, we report the amino acid
sequence and the electrophysiological characteriza-
tion of a peptide that we decided to call Aa1 (be-
cause it is peptide 1 of our studies, from the venom
A. australis Garzoni). Structural features show that it
belongs to group 4, and should be given the system-
atic number alpha KTX4.4, as discussed below. It
entirely blocks only one type of K currents from
cerebellum granular cells. The membrane of these
cells contains several types of potassium channels
with di¡erent kinetics and pharmacology [22]. Using
the patch-clamp technique in the whole-cell con¢gu-
ration system, we have characterized the outward
potassium currents. Two di¡erent currents were re-
corded: a fast transient, low-voltage activated cur-
rent (IA), blocked by 4-aminopyridine (4-AP), which
decays to a steady-state current level in about 100 ms
due to the second component. It has electrophysio-
logical and pharmacological properties similar to the
classical squid axon potassium current (Id) [22]. Pep-
tide Aa1 was shown to block speci¢cally only the fast
K currents of these cells.
2. Materials and methods
2.1. Materials
A. australis Garzoni (AaG) scorpion venom was
purchased from Latoxan (Rosans, France). The cul-
ture medium was from Gibco (Rockville, MD,
USA). Water double distilled on quartz was used
for all experiments. Reagents and solvents used for
chromatography and electrophysiological experi-
ments were analytical grade, obtained as previously
described [23].
2.2. Separation procedure
One hundred milligrams of venom from AaG was
dissolved in 8 ml of double distilled water, centri-
fuged at 15 000Ug for 15 min and the supernatant
was lyophilized and kept at 320‡C until used. The
various active fractions used in this work were ob-
tained by chromatographic separations, as previously
described [23]. Brie£y, the soluble venom was ini-
tially applied to a Sephadex G-50 column. The sub-
fraction corresponding to the peptides of interest
(range 4000 molecular mass) were further separated
on carboxymethyl-cellulose (CM-cellulose) ion ex-
change resins, followed by high-performance liquid
chromatography (HPLC). Peptide concentration
was estimated on absorbance at 280 nm, in which
one absorbance unit, using 1 cm pathlength was con-
sidered to contain 1 mg/ml peptide.
2.3. Amino acid sequence determination
Amino acid analysis was performed using a Beck-
man 6300E analyzer (Palo Alto, CA, USA) on sam-
ples hydrolyzed for 20 h, at 110‡C, in sealed and
evacuated tubes, in the presence of 6 N HCl and
0.2% phenol for protection of tyrosines. A mass spec-
trometer Voyager-DE STR from PerSeptive Biosys-
tems (Framingham, MA, USA) was used for deter-
mination of the molecular mass and for analyzing
the mass changes after hydrolysis using the Sequa-
zyme C-Peptide Sequencing Kit from the same com-
pany (PerSeptive Biosystems). Amounts of about 0.5
Wg of toxin Aa1 were used for individual assays fol-
lowing the manufacturer’s conditions. Additional hy-
drolysis of toxin was performed with the following
enzymes: Protease V8 from Staphylococcus aureus,
Arg C and Lys C endopeptidases (all from Boehr-
inger Mannheim, Mannheim, Germany). The diges-
tion with protease V8 was conducted in 100 mM
ammonium bicarbonate bu¡er, pH 7.9, using 40 Wg
toxin, whereas the digestion with Lys C endopepti-
dase was done in 25 mM Tris^HCl bu¡er, pH 8.5
added of 1 mM EDTA, with 30 Wg toxin. The hy-
drolysis with Arg C peptidase was performed with
5 Wg toxin in 100 mM Tris^HCl, pH 7.6 in the pres-
ence of 10 mM CaCl2, 2.5 mM DTT and 0.25 mM
EDTA. The ratio enzyme:toxin, was always 1:20.
The incubation of the reaction was maintained for
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4 h at 36‡C. The products were separated by HPLC,
using a Millennium 2010 system from Waters (Mill-
ford, MA, USA) equipped with a photodiode array
detector, and the separation gradient was from sol-
vent A (0.12% tri£uoroacetic acid in water) to 60% B
(0.1% tri£uoroacetic acid in acetonitrile) for 1 h. All
the peptides obtained were loaded into the Beckman-
Porton LF3000 Protein Sequencer (Fullerton, CA,
USA), for sequence determination. Repeated prepa-
rations were performed, in which aliquots of toxin
were reduced and carboxymethylated, prior digestion
with enzymes (v.g., protease V8 and Lys C endopep-
tidase). However, most sub-peptides were reduced
and alkylated in the machine, using the protocol de-
scribed by the manufacturer.
2.4. Cell culture
Experiments were performed on cerebellum gran-
ular cells in primary culture obtained from 8-day-old
Wistar rats. Dissociated cell cultures were prepared
by trypsin digestion and mechanical trituration, fol-
lowing the procedure of Levi et al. [24]. Cells were
plated at a density of 2.5W106 per dish, on 35 mm
plastic dishes or on glass coverslips, coated with 10
mg/ml poly-L-lysine and kept at 37‡C in humidi¢ed
95% air/5% CO2 atmosphere. Experiments were per-
formed 5^10 days after plating.
2.5. Patch-clamp measurements
Ionic currents were recorded in whole-cell patch-
clamp technique con¢guration [25]. Patch pipettes
were made from borosilicate glass (1.5 mm o.d.,
1.17 mm i.d., from Clark Electromedical Instru-
ments) and ¢re polished to obtain resistances be-
tween 2^4 MOhms. Cell responses were ampli¢ed
and ¢ltered at 2 kHz by an AxoPatch-1D (Axon
Instruments). Both stimulation and data acquisition
were performed with a 16-bit AD/DA converter
(DigiData 1200, Axon Instruments) controlled by a
computer PC 486. The whole-cell currents elicited by
a 150^200 ms-long voltage steps between 360 and 80
mV from 350 and 380 mV holding potentials (HP)
were acquired at a sampling time of 200 Ws. The
capacitive transient component and series resistance
of recorded currents were analog-compensated.
When the voltage error associated with the uncom-
pensated series resistance was more than 10 mV, the
membrane potential was corrected o¡ line. P/4 leak-
age subtraction was performed on line. Data were
stored on hard disk for subsequent analysis. The
composition of the pipette ¢lling solution was the
following (in mM): 90 KF, 30 KCl, 2 MgCl2,
2 EGTA, 5 NaCl, 10 HEPES, 30 glucose, pH 7.35.
The external standard solution, designed to suppress
Na and Ca2 currents, was (in mM): 135 NaCl,
2.5 KCl, 1 MgCl2, 1.8 CaCl2, 0.3 tetrodotoxin,
0.2 CdCl2, 10 HEPES, 10 glucose, pH 7.35. Puri¢ed
peptides were directly added in the chamber contain-
ing 200 Wl of external solution.
All the experiments were carried out at room tem-
perature (23 þ 2‡C).
3. Results
3.1. Amino acid sequence determination
Results of the amino acid analysis showed that
toxin Aa1 contains no histidine, leucine, phenylala-
nine or methionine and its minimum molecular
weight was compatible with the presence of about
37^40 amino acid residues. Tryptophan cannot be
determined in hydrolysates with HCl, but this amino
acid was also shown to be absent by direct sequenc-
ing and molecular mass determination of the native
peptide. Direct sequencing trials of the toxin gave no
amino acid residues, con¢rmed that the N-terminal
Fig. 1. Amino acid sequence of toxin Aa1. The overlapping
amino acid sequences were obtained from HPLC separated pep-
tides, as described in Section 2. Peptide from position 4 to 32
was obtained after protease V8 digestion, and glutamic acid at
position 3, was surmised from the same enzymatic reaction
(V8), whereas endopeptidase Arg C gave peptides from position
20 to 32 and 33 to 36. Lys C endopeptidase digestion produced
peptide corresponding to positions 28^34. Position 37 was di-
rectly determined by mass spectrometry after digestion with car-
boxypeptidase Y, whereas positions 1 and 2 were obtained
from a combination of amino acid analysis, mass spectrometry
and sequencing results.
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position was blocked [23]. Under digestion with pro-
tease V8, a sample of reduced and alkylated toxin
gave a peptide, whose sequence identi¢ed 29 amino
acids, shown below the full sequence in Fig. 1, which
corresponds to amino acids in position 4^32 of the
full sequence. Since the speci¢city of this enzyme
supposes that the previous residue is a glutamic
acid, in our experimental conditions, the amino
acid in position 3, was surmised to be glutamic
acid (see E in Fig. 1). One of the peptides obtained
after digestion with Lys C endopeptidase gave the
sequence starting at cysteine in position 28 to valine
in position 34 (indicated in Fig. 1). Enzymatic cleav-
age with Arg C gave several sub-peptides one of
them corresponded to the overlapping sequence
from cysteine-33 to tyrosine-36, but gave also anoth-
er peptide corresponding to sequence 20 to arginine-
32. The last residue, proline-37, was obtained by
mass spectrometry, after carboxypeptidase Y diges-
tion. Three of the samples showed masses of 96.12,
97.09 and 97.04 which are consistent with the as-
sumption that the last residue is proline. The ¢rst
residue was assumed to be a pyroglutamic acid,
based on the amino acid analysis, which showed a
result compatible with the presence of more than two
glutamic acids or glutamines in the sequence. It is
worth remembering, that under acid hydrolysis, glu-
tamine is eluted as glutamic acid. The value obtained
in the amino acid analyzer, was compatible with the
presence of more than two glutamic acids in the pep-
tide (3.8 mol per toxin molecule). Thus, the presence
of a pyroglutamic acid as ¢rst amino acid was as-
sumed. The molecular mass obtained with native
sample showed that the exact molecular mass of tox-
in Aa1 was 3850.83. When the 36 amino acids al-
ready positioned into the sequence were integrated,
a value for the molecular mass of 3735.74 was found.
The di¡erence is 114.61 that ¢ts with the mass of
asparagine; for this reason, amino acid in position
2 was thought to be occupied by asparagine. This
position for asparagine (or aspartic acid) is also par-
tially supported by the results of amino acid analysis
of the native toxin. The integrated value for aspartic
acid plus asparagine, in toxin Aa1, was 2.45 per mol-
ecule (not shown), which means it could have two or
three aspartic acids. It is convenient to remember
that asparagine under acid hydrolysis gives aspartic
acid. Since the molecular mass of the toxin obtained
by mass spectrometry suggested the lack of aspara-
gine, we included this residue in position 2. Also,
several other K channel scorpion toxins end by a
tripeptide cysteine^tyrosine^proline, reason for plac-
ing asparagine in position 2, instead of 36, as dis-
cussed below.
3.2. Aa1 toxin blocks the transient K+ channel in rat
cerebellum granular cells
The puri¢ed peptide blocks currents £owing
through the fast activating and inactivating K chan-
nels with high a⁄nity only when applied to the extra-
cellular side of the channel. Fig. 2 shows recordings
from macroscopic K current elicited by depolariz-
ing pulses in the control solutions (Fig. 2A), and
after the addition of a saturating concentration (2.7
Fig. 2. E¡ect on IA type K current Aa1 scorpion toxin acts
on the IA type potassium current selectively. (A) Family of con-
trol currents in response to voltage step from 360 to +40 mV
in 20-mV increments. (B) Currents after bath application of 2.7
WM Aa1. (C) Current^voltage relationship for peak IA in con-
trol condition, in presence of 2.7 WM Aa1 and after recovery.
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WM) of Aa1 to the external solution (Fig. 2B). The IA
type component of the current was completely
blocked while Id type remains almost unaltered.
The channels were activated by 200-ms pulses deliv-
ered at the rate of one every 5 s from an holding
potential of 380 mV, to allow a complete recovery
from inactivation. Fig. 2C illustrates the current^
voltage relationships for the peak. The recovery of
the current after washing-out the toxin was never
complete. At lower concentrations of Aa1 toxin
and for perfusing periods of several minutes, the re-
covery did not overcome the 80% of control currents
(60 þ 20%, n = 25).
3.3. Electrophysiological features of Aa1 toxin
interaction with IA type current
We have studied the electrophysiological e¡ects of
this toxin on the kinetics of the fast activating and
inactivating potassium current in order to elucidate
the blocking mechanism. For this purpose, the Id
type potassium current was suppressed by 20 mM
tetraethylammonium ion at the external side of the
cell.
3.3.1. Activation
The activation curve vs. membrane potential is
shown in Fig. 3A. It represents the dependence of
the open probability of channel from the test po-
tential. It has been obtained calculating the ratio
I/(V3Vrev), (Vrev =397.5 mV for potassium ion),
and is ¢tted to a Boltzmann distribution I/Imax =
1/{1+exp[(V3V0:5)/k]}, where V is the test potential,
V0:5 is the midpoint potential and 1/k is the steepness
of the curve. The best ¢t gave a V0:5 of 1 þ 3 mV with
a 1/k value of 0.051 mV31 in the control condition,
whereas in the presence of Aa1 toxin, the V0:5 was
2 þ 2 with a 1/k value of 0.043 mV31. Thus there are
no signi¢cative di¡erences between the parameters in
the control and toxin-containing conditions. Another
important value to describe the activation kinetic of
the current is the time between the starting potential
pulse and the maximum of the current (time-to-peak,
Fig. 3B). The toxin does not alter the rate of rise of
the peak current.
3.3.2. Inactivation
The steady-state inactivation process (hr) was
studied by using a two-pulse protocol (inset of Fig.
4A) consisting of a 480 ms-long prepulse from 3120
to 330 mV, stepped by 10 mV, followed by a 50-ms-
long test pulse to 50 mV. K channel availability was
evaluated as the ratio I/Imax, namely the ratio be-
tween each current dependent on di¡erent precondi-
tioning potentials and the maximum current corre-
sponding to a 3120 mV preconditioning pulse. Fig.
4A gives the I/Imax values vs. voltage curve, ¢tted to
a Boltzmann equation. Value for V0:5 was 373 þ 0.6
mV with a 1/k of 0.12 mV31 in the control condition,
whereas in the presence of toxin, it was V0:5 of
378.8 þ 0.8 mV, with a 1/k value of 0.1 mV31. Aa1
at the concentration 80 nM only marginally shifts the
curves towards more negative potential (5.8 mV at
the half-inactivated point). The recovery time from
inactivation (Fig. 4B) was evaluated after a depola-
rizing prepulse to 0 mV for 0.5 s and a long-variable
pulse to 390 mV where the channels reactivate (inset
of Fig. 4B). The value I/Imax was measured to +50
Fig. 3. Current activation kinetics Aa1 80 nM does not in£u-
ence current activation kinetics. (A) Open probability of K
channels vs. test potential. (B) Time-to-peak for transient cur-
rent from HP =390 mV (mean þ S.D. n = 7, 8).
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mV test potential and plotted vs. the length of the
390 mV variable pulse in control situation and after
adding Aa1 80 nM. Inactivation time courses of the
transient current were found to be voltage indepen-
dent and could be ¢tted by one exponential curve.
The inactivation time constants in control experi-
ments and in the presence of the toxin were plotted
vs. voltage in Fig. 4C. The invariance of the last two
results con¢rm that the shift on the hr is not signi¢-
cant.
3.3.3. Voltage dependence
Many toxins show di¡erent a⁄nities for the bind-
ing site when di¡erent potentials are applied to the
membrane. It is probably due to an electrostatic in-
teraction between the electric charges present on the
toxin surface and the voltage drop across the pore
[9,26].
To study the voltage dependence, experiments
were performed by varying the holding potential
and observing the degree of blockade at a ¢xed test
potential. The holding potential results show no sig-
ni¢cant di¡erences on the extent of blockade and the
depolarized test voltage does not in£uence Aa1 block
(data not shown).
3.3.4. Closed channel block
The experiments of Fig. 5 were performed in order
to assess the possible blocking e¡ect of the toxin on
closed channels [27]. The ¢rst test pulse applied after
a very negative holding potential at 390 mV after
5 min from toxin addition, greatly reduced open chan-
nel probability. Exponentials were ¢t to the decay of
each trace in Fig. 5 and extrapolated to the begin-
ning of the voltage step to estimate the degree of
block before channel opening. A 45% block precedes
macroscopic activation during the 5 min. of exposure
to 90 nM Aa1. The following voltage step, delivered
1 min later (6 min) elicited the same current: the
blockade did not increase after the activation of the
channel with the ¢rst pulse after 5 min of perfusion
in the presence of the toxin. Thus the Aa1 peptide
Fig. 4. Aa1 e¡ects on current inactivation kinetics. (A) Steady-
state inactivation curves for granular cells before and after ex-
posure to 80 nM Aa1. Data represents peak IA (mean þ S.D.,
n = 7) at +50 mV after a 0.48-s prepulse to the indicated poten-
tial. Experimental points were ¢tted to the Boltzmann equation
(see text). (B) Normalized time course of IA reactivation at 390
mV after a depolarizing prepulse to 0 mV for 0.5 s. (C) Inacti-
vation time constant vs. depolarizing pulses.
Fig. 5. Blockage of closed and open channels. Aa1 block of
‘closed’ channels is not in£uenced by channel opening: records
represent consecutive and exclusive current response at +40 mV
after control condition and after 5 min and 6 min of exposure
to 90 nM Aa1. HP =390 mV.
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blocks the open and the closed channel indepen-
dently.
3.3.5. The kinetics of toxin block
Fig. 6A and B shows the time courses of a multi-
pulse wash-in/wash-out experiment using 270 nM of
Aa1 toxin. The cell was held at 380 mV and then
repeatedly depolarized to 40 mV to assess unblocked
current level. In this experiment, pulse of 200 ms
were collected at 5 s intervals. Plots of unblocked
current vs. time are well ¢tted by single exponential
functions for both toxin wash-in and wash-out.
Since toxin binds in reversible manner and does
not alter channel gating, the time constants for re-
laxation to equilibrium block re£ects the progress of
the binding reaction. The Aa1 reaction with the
binding site of the transient K channels, like the
block of BK channels and the Shaker K channels




Channel : Aa1 1
where Kon = 11.9 þ 0.3W106 M31 s31 is the second-or-
der association rate constant and Koff = 1.8 þ 0.1 s31
the ¢rst-order dissociation rate constant. The time
constant to approach to equilibrium blockade is giv-
en by don = 1/(Kon[Aa1]+Koff ) and that for wash-out
is given by doff = 1/Koff . The fraction of unblocked
current at equilibrium (fu) in the presence of toxin
concentration [Aa1], is related to Kon and Koff ac-
cording to fu = Koff /(Kon[Aa1]+Koff ) and Ki = Koff /
Kon = 150 þ 12 nM; this last value is not signi¢cantly
di¡erent from 134 þ 26 nM shown in the paper by
Pisciotta et al. [23]. Thus the desired rate and inhi-
bition constants are estimated. Fig. 6C shows the
e¡ects of increasing toxin concentration on block
kinetics. As required by simple bimolecular scheme,
association rate increases linearly with toxin concen-
tration, whereas the dissociation rate remains con-
stant.
4. Discussion
The amino acid sequence reported here is consis-
tent with the experimental data obtained. Direct se-
quencing con¢rmed amino acids in positions 3^36.
The amino acids in positions 1, 2 and 37 are assumed
based on amino acid analysis and molecular mass
determinations. Asparagine (or aspartic acid as men-
tioned in Section 3) at position 2, could also be in
position 36, shifting the positions one residue to the
left on Fig. 1. In other words, position 2 would be
glutamic acid and position 35 would be tyrosine, 36
asparagine and 37 proline. There is a remote possi-
bility that the N-terminal pyroglutamic acid could be
Fig. 6. E¡ect of Aa1 on blocking kinetics. (A) Peak current
during toxin wash-in is plotted vs. time. (B) Time course of
peak current during toxin wash-out. (C) The apparent ¢rst-or-
der rate constant for association (on, Kon[Aa1]) and dissociation
(o¡, Koff ) are plotted as a function of toxin concentration. The
slope of the line through the ¢rst-order association rate con-
stant corresponds to a second-order association rate constant
Kon.
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some other modi¢ed amino acid that would sum up
the molecular mass of asparagine. If we compare the
amino acid sequence of Fig. 1 with data in the liter-
ature, it is evident that toxin Aa1 bears resemblance
with other K channel speci¢c toxins in its C-termi-
nal amino acid sequence. Some of them have the
terminal sequence cysteine^tyrosine^proline, just as
toxin Aa1 of this work (see toxin Ts II-9 in Fig. 7,
also toxin Clltx1 from Centruroides limpidus limpidus
and the cobatoxins 1 and 2 from Centruroides noxius,
reviewed in Possani et al. [2]).
In Fig. 7, we added a comparative table with the
other known sequences, based on a recent publica-
tion, where a scienti¢c nomenclature was proposed
by a panel of international scientists working in this
¢eld [28]. According to this proposition, there are at
least 12 di¡erent subfamilies of scorpion toxins spe-
ci¢c for K channels, denominated alpha K scorpion
toxins, from numbers 1 to 12, and sub-numbers ac-
cording to the chronological discovery and report of
the toxins. For Fig. 7, only one representative exam-
ple of each subfamily was selected, and aligned with
gaps (3) to increase similarities. Pairwise compari-
sons of toxin Aa1 with each one of the other 12
toxins gave an identity value relatively poor, which
means that this toxin is quite di¡erent from all the
other known ones, thus far in terms of total identity
(see percentage in the legend for Fig. 7). The percent-
age of identity for toxin Aa1 found with other toxins
varies from 19 to 50%, when calculated for each one
of the groups starting with number 1 until 12. The
closest one is group 4, that gave 50% identity to
toxin II-9 (also called Kalpha) from Tityus serrulatus
[28]. A novel toxin belonging to this group was re-
ported recently, which was classi¢ed as alpha
KTx4.3, isolated from the venom of the scorpion
Tityus discrepans [29]. Thus, the scienti¢c number
of toxin Aa1 should be alpha KTx4.4. It is worth
observing that only six residues, all cysteines, are
identical (see consensus sequence at the bottom of
Fig. 7). It also should be mentioned that a novel
class of scorpion toxins was discovered recently: Erg-
toxin, speci¢c for ERG K channels [30], with no
similarities to any one of the toxins listed in the 12
subfamilies mentioned [28], for this reason, it was not
included in our comparison of Fig. 7.
Concerning the physiological action, the results
described here indicate that toxin Aa1, isolated
from the scorpion venom A. australis Garzoni, af-
fects the fast activating and inactivating K current
in cerebellar granule cells. The toxin, added to the
external solution, reduces in a selective manner the
IA-type component with a Ki = 150 þ 12 nM. In the
same conditions, the other K current, identi¢ed as
delayed recti¢er (Id), was not a¡ected. The recovery
is not fully reversible. Long-lasting washing partially
removes the block, very likely due to the run-down
of the currents occurring in the mean time.
Fig. 7. Amino acid sequence comparison of K channel-speci¢c toxins. The primary structure of representative examples of each of
the 12 subfamilies of alpha KTX scorpion toxins, taken from Tytgat et al. [28], are compared with toxin Aa1. Gaps (3) were arti¢-
cially introduced in order to enhance identity. The percentage of identity found was: 40, 32, 37, 50, 29, 36, 22, 24, 19, 34, 21 and
27%, respectively, when calculated pairwise against toxin Aa1, for each one of the groups starting with group 1 until 12. The ¢rst se-
quence is from this work (Aa1 toxin), the others were from reference [31]: ChTx, charybdotoxin; NTx, noxiustoxin; KTX, Kaliotox-
in; Ts II-9 or Kalpha, and TsTX IV, toxins from T. serrulatus ; LeTxI, leiurustoxin-I or scyllatoxin; Pi1 and Pi2, toxin 1 and 2 from
Pandinus imperator, BmPO2 toxin from Buthus martensi ; toxin 2 from Buthus sindicus ; CoTx1, cobatoxin 1 from C. noxius ; PbTX1,
toxin 1 from Parabuthus transvaalicus.
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We have investigated the mechanism of block by
Aa1 and the most relevant features are the following:
(a) the kinetics of the channels are not a¡ected by
Aa1; (b) the blockade is independent of the test po-
tential and is not a¡ected by changing in holding
potential; (c) the toxin inhibits the channel both in
open or closed state; and (d) the blockade re£ects
the formation of a bimolecular toxin^channel com-
plex, where the second-order association constant
Kon is 11.9 þ 0.3W106 M31 s31, increasing linearly
with toxin concentration and the dissociation rate
Koff 1.8 þ 0.1 s31 remains constant.
These results support the conclusion that toxin
Aa1 blocks the transient K channels of the cerebel-
lum granular cells in a simple bimolecular and pore-
directed binding fashion. This mechanism of block-
ade resembles that described for other K channels
by MacKinnon and Miller [11] and Giangiacomo et
al. [19] using Charybdotoxin and Iberiotoxin, respec-
tively. Actually, toxin Aa1 has a blocked N-terminal
amino acid (pyroglutamic acid), similar to Charyb-
dotoxin and Iberiotoxin, for which the primary
structure identity is in the order of 40%. We are
con¢dent that Aa1 is a new example of a very inter-
esting scorpion venom peptide, with exquisite prefer-
ence for the transient K channels. The blockade of
these channels, with no e¡ect on Id type of currents
of the granular cells studied, shows its potential use-
fulness for speci¢c K channels characterization. The
Ki value for the transient K channels (150 nM),
contrast with the e¡ect on Shaker B potassium chan-
nel expressed in Xenopus laevis oocytes, where a Ki of
4.5 WM was obtained for Aa1 [31].
Thus, we conclude that toxin Aa1 is a new and
valuable ligand to recognize di¡erent subtypes of
fast activating and inactivating K channels and
will also provide an interesting instrument to inves-
tigate the structure^function relationship of these
voltage-dependent K channels.
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